Aurolife Pharma LLC receives EIR for plant at Raleigh, North Carolina, USA

The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma LLC, a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has received an establishment inspection report (EIR) mentioning the inspection a voluntary action initiated (VAI) from the United States Food and Drug Administration (US FDA) and with this, the US FDA pre-approval inspection and GMP inspection are concluded.

Source : Equity Bulls

Keywords

AurobindoPharma AurolifePharmaLLC Raleigh NorthCarolina Plant USFDA EIR